• Home
  • Victims
    • Vaccine Victims Memorial
    • Gardasil & Silgard
      • G / S Australasia
        • G / S Australia
        • G / S New Zealand
      • G / S Europe
        • G / S Czech Republic
        • G / S Denmark
        • G / S France
        • G / S Germany
        • G / S Ireland
        • G / S Italy
        • G / S Norway
        • G / S Scotland
        • G / S Spain
        • G / S United Kingdom
      • G / S N. America
        • G / S Canada
        • G / S Mexico
        • G / S United States
      • G / S S. America
        • G / S Brazil
        • G/S Colombia
    • Cervarix
      • Cervarix Asia
        • Cervarix India
        • Cervarix Philippines
      • Cervarix Europe
        • Cervarix Czech
        • Cervarix Netherlands
        • Cervarix Scotland
        • Cervarix Slovakia
        • Cervarix Spain
        • Cervarix UK
      • Cervarix N. America
        • Cervarix Mexico
  • Resources
    • HPV Testing Resources
      • Pre-HPV Vaccination
      • Post-HPV Vaccination
    • Medical Professionals
    • Vaccine Injury Attorneys
    • Political Action Groups
    • Vaccine Groups
    • Vaccine Victims Hotline
  • SANE Vax Press Releases
  • Videos
    • Vaccine Safety Videos
    • Vaccine Victim Videos
    • Pharma Videos
  • About
    • About Us
    • Who We Are
    • Press Releases
    • SANE Vax in the News
    • Contact Us

SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

  • NEWS
    • Government Agencies
      • African
      • Asian
      • Australasian
      • European
      • North American
      • South American
      • United Nations
      • WHO
    • Pharmaceutical Companies
      • CSL Biotherapies
      • GlaxoSmithKline
      • Inovio Pharmaceuticals
      • Liquidia Technologies
      • Merck & Co.
      • Novartis
      • Pfizer
      • Qiagen
      • Sanofi Aventis
      • Sanofi Pasteur MSD spmsd
      • Wyeth Laboratories
    • Science & Medicine
      • Cancer
      • Clinical Trials
      • Environmental Health
      • Heavy Metal Toxicity
      • HPV Science
      • Influenza
      • Meningitis
      • Pertussis
      • Pharmaceuticals
      • Rotavirus
      • STD’s
      • Vaccine Science
      • Women’s Health
    • Vaccine Adverse Events
    • Vaccine Injury Reporting
      • VAERS
      • VAMPSS
    • Vaccine Litigation
    • Vaccine Marketing
    • Vaccine Politics/People
    • Vaccine Victims
      • Cervarix Injuries
      • DTP/DTaP Injuries
      • Fluvax Injuries
      • Fluzone Injuries
      • Gardasil / Silgard Injuries
      • Menomune Injuries
      • MMR Injuries
      • Polio Vaccine Injuries
      • Synflorix Injuries
      • Yellow Fever Vaccine
    • Vaccines
      • Anthrax
      • Breast Cancer
      • Chicken Pox
      • Cholera
      • Combination Vaccines
      • Diphtheria
      • Hepatitis B
      • HPV
      • Influenza Vaccines
      • Malaria
      • Measles
      • Meningitis Vaccines
      • MRSA
      • Mumps
      • Norovirus
      • Pertussis Vaccines
      • Pneumococcal Disease
      • Polio
      • Rotavirus Vaccines
      • Shingles
      • Smallpox
      • TB
      • Tetanus
      • Typhoid
      • Yellow Fever Vaccine
    • Vaccines and the Media
  • WORLD NEWS
    • Africa
    • Asia
    • Australasia
    • Europe
    • North America
    • South America
  • RESEARCH
    • Cancer Research
    • Cervarix Vaccine
    • Gardasil/Silgard Vaccine
    • Human Pap. Research
    • Immunization Practices
    • Neurology
    • Vaccine Adjuvants
    • Vac. Ingredient Research
    • Vaccine Injuries
    • Vaccine Preservatives
    • Vaccine Related Research
    • Vaccine Safety
  • CITIZENS SPEAK
    • Cervical Cancer Debate
    • HPV Vax
      • Australian Concerns
      • Canadian Concerns
      • Irish Concerns
      • Spain Concerns
      • UK Concerns
      • United States Concerns
You are here: Home / NEWS . . . . . . . . / Vaccines / HPV / Cervarix / Vaccine Markets A Refuge for Big Pharma

Vaccine Markets A Refuge for Big Pharma

February 8, 2011 By Jonathan 1 Comment

Drug Discovery & Development

January 13, 2011

Unlike several life science sectors that felt the impact of the global crisis, the human vaccines market remained resilient to the global economic recession. Irked by weakened pipelines and growing pressure from patent expiries, the big pharma majors such as AstraZeneca and Pfizer found vaccines industry as safe avenue to invest and register guaranteed revenues. Vaccines register a higher profit margin in comparison to generic drugs, but lower than branded ones. Regional players from fast developing vaccine markets, such as India and China, are primarily engaged in meeting demands of public supply for routine and immunization vaccines. Driven by global H1N1 outbreak, Pandemic Influenza Vaccines registered high growth in 2009. The H1N1 pandemic increased sales of vaccine makers, including GlaxoSmithKline, Sanofi-pasteur, Novartis, Baxter, and MedImmune.

Human vaccines, earlier considered as a low profit yielding business, have transformed into cash cows for global pharmaceutical giants. Patents for human and animal vaccines accepted by European and US patent authorities totaled nearly 250 in 2007. Prophylactic vaccines represents the biggest earner in human vaccines market. However, therapeutic vaccines market is still untapped. Therapeutic vaccines is projected to grow rapidly over the coming years, subject to the regulatory approvals. Companies, both established and upcoming, are investing a major chunk of research resources into development of therapeutic vaccines capable of fighting diseases such as cancer, AIDS, and other diseases. Encouraging results, such as enhanced stability, production scalability, and immune response have also been reported in the field of DNA-related vaccines. Addiction vaccines are also forecast to witness phenomenal growth.

Product extension, which hitherto was a common practice in the pharma sector, is now finding success in the vaccines industry. Manufacturers are making constant efforts to introduce additional indications of established products to keep up profit margins. For instance, the best selling vaccines, such as Gardasil and Prevnar, are being evaluated for the prevention of other related diseases or infections. Prevnar, a 7-valent vaccine for protection against the seven serogroups, has been evaluated as Prevnar-13 for protection against six more serogroups. In December 2009, Prevnar/Prevenar 13 Infant obtained approval in the EU member states. The vaccine was approved in the US in February 2010. Gardasil, which was approved for the prevention of four strains of HPV (human papillomavirus), is currently being tested for the prevention of nine more strains.

Read Full Article…

Related

Filed Under: Cervarix, Gardasil / Silgard, Pharmaceuticals, STD's, Vaccine Adverse Events Tagged With: Alopecia totalis, Anal Cancer, autism, Autoimmune Diseases, cervarix, Cervical Cancer HPV, Gardasil/Silgard, GlaxoSmithKline, HPV VACCINES, immunizations, Merck, pharmaceuticals, STD's, Vaccine Adverse Reactions

Trackbacks

  1. Tweets that mention Vaccine Markets A Refuge for Big Pharma – SaneVax General Blog -- Topsy.com says:
    February 8, 2011 at 10:26 pm

    […] This post was mentioned on Twitter by SaneVax, SaneVax. SaneVax said: https://sanevax.org/blog/?p=2000 […]

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Follow Us

SaneVax on FacebookSaneVax on TwitterSaneVax on LinkedInSaneVax on YoutubeSaneVax RSS Feed

Help Support SaneVax

Notice: We need your support. This massive research & presentation comes from a team of volunteers. We need your help to keep this critical information available.



SaneVax relies on support from participants like you. We are a 501 (c)(3) non-profit corporation, donations are tax deductible. Help keep this venue available and support the spirit – Thank you!

This Week’s Survivor

Update on Shania “The Flyer” Mandurah, Western Australia

Categories

Links

  • Creating an HPV Industry
  • File a VAERS Report
  • Gardasil and Unexplained Deaths
  • HPV Industry Timeline
  • HPV Mechanisms of Action in Women
  • HPV Vaccine Fact Sheet
  • Petition: Rescind HPV Vaccine Approval
  • Presentation to the FDA
  • Supreme Court Arguments

HPV Vaccine VAERS Reports

Description 12/14/2019  TOTAL
Disabled 3,092
Deaths 523
Did Not Recover 13,072
Abnormal Smear 695
Cervical Cancer 186
Infertility 52
Life-threatening 1,001
Emergency Room 15,419
Hospitalized 6,448
Extended Hosp. Stay 304
Serious 9,497
Total Adverse Events 64,270

Access expanded report here.

Related

Subscribe2


 

Log In

Featured Video

Path’s HPV Trials in India: Troubling Questions

News

SaneVax News Blog!
News

Videos

Safety • Victims • Pharma
No Genetic Epidemic

Contact

Contact S.A.N.E.Vax
S.A.N.E.VAX log thumbnail

Copyright © 2025 SaneVax, Inc. · Site by TheWebElves.com a div. of KalaRhythms.org · Log in